Abbott India (NSE:ABBOTINDIA) ROCE % : 40.76% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Abbott India ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Abbott India's annualized ROCE % for the quarter that ended in Mar. 2024 was 40.76%.

Abbott India ROCE % Historical Data

The historical data trend for Abbott India's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India ROCE % Chart

Abbott India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

34.23

34.55

37.69

40.49

45.28

Abbott India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															37.31	47.03	51.21	52.04	40.76

Abbott India ROCE % Calculation

Abbott India's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	16301.5	/	( ( (45555.1 - 12060.2)	+	(51934.9 - 13427.2) )	/ 2 )
	=	16301.5	/	( (33494.9	+	38507.7)	/ 2 )
	=	16301.5	/	36001.3
	=	45.28 %

Abbott India's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	15697.6	/	( ( (0 - 0)	+	(51934.9 - 13427.2) )	/ 1 )
	=	15697.6	/	( ( 0	+	38507.7 )	/ 1 )
	=	15697.6	/	38507.7
	=	40.76 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Abbott India (NSE:ABBOTINDIA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Abbott India ROCE % Related Terms

Thank you for viewing the detailed overview of Abbott India's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott India (NSE:ABBOTINDIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (NSE:ABBOTINDIA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

500488:India

Address

15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.abbott.co.in

Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (NSE:ABBOTINDIA) Headlines

No Headlines